News and Announcements
Inside Healthcare Investing: How KP Rx is Transforming Australia’s Biotech Industry
- Published November 08, 2024 5:04AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Join us in this in-depth interview with Hashan De Silva, Founder of KP Rx, as he shares the journey behind launching a specialist healthcare VC firm. Learn how KP Rx is transforming biotech and medical device investments in Australia and New Zealand by capitalising on key market advantages. Hashan explains the firm’s unique approach, valuation arbitrage, and insights into healthcare investment strategies that have yielded significant success.
Executive Interviews
AI is The Cheapest, Highest-Leverage Investment You Will Ever Make
AI tools offer a 10x productivity increase for a minimal monthly cost, making them the highest-ROI investment in business today. However, this massive potential remains dormant. The real opportunity is not in owning the tools, but in having the strategic playbook to deploy them organization-wide and build a defensible competitive advantage.
Forging a $100M Future: Why Prime Financial Puts People First in its Acquisition Strategy
ASX-listed Prime Financial Group is on an ambitious path to a $100 million revenue target. Chairman Simon Madder reveals their playbook isn’t just about capital; it’s about a founder-focused acquisition strategy where cultural fit is the ultimate litmus test. Discover how their unique partnership model, which includes offering significant equity to incoming founders, is fuelling one of the sector’s most compelling growth stories.
Wholesale Investor and MTPConnect Announce Strategic Partnership to Accelerate Investment in Australia’s Life Sciences Sector
Wholesale Investor and MTPConnect announce a landmark strategic partnership to bridge the funding gap in Australia’s life sciences sector. The collaboration creates a comprehensive capital engagement program, culminating in the Life Sciences Investor Day at the Emergence 2026 Conference
Backed By Leading Investment Groups and Family Offices
